Skip to content
2000
Volume 2, Issue 2
  • ISSN: 2666-7967
  • E-ISSN: 2666-7975

Abstract

Background: COVID-19 debilitated communities globally in varying complexities and capacities in recent months. Objective: The epigenetic changes in the COVID-19 patients were discussed in this article to explore various processes contributing to disease severity and elevation of risk due to infection. Methods: Percentages of hospitalization, with and without intensive care, in the presence of diseases with increased ACE2 expression, were compared, based on the best available data. Further analysis compared two different age groups, 19-64 and ≥65 years of age. Result & Conclusion: The COVID-19 disease is observed to be the most severe in the 65 and-higher-age group with pre-existing chronic conditions. This observational study is a nonexperimental empirical investigation of the outcomes of COVID-19 in different patient groups. Results are promising for conducting clinical trials with intervention groups. To ultimately succeed in disease prevention, researchers and clinicians must integrate epigenetic mechanisms to generate valid prescriptions for global well-being.

Loading

Article metrics loading...

/content/journals/covid/10.2174/2666796701999201005212515
2021-02-01
2025-09-01
Loading full text...

Full text loading...

/content/journals/covid/10.2174/2666796701999201005212515
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test